• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与双相情感障碍新发病例相关的药物使用、服务利用及医疗费用:来自回顾性索赔数据库的证据

Medication use, service utilization, and medical costs associated with new episodes of bipolar disorder: evidence from a retrospective claims database.

作者信息

Ohsfeldt Robert L, Lage Maureen J, Rajagopalan Krithika

机构信息

Texas A&M Health Science Center, College Station.

出版信息

Prim Care Companion J Clin Psychiatry. 2007;9(4):280-6. doi: 10.4088/pcc.v09n0405.

DOI:10.4088/pcc.v09n0405
PMID:17934552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2018844/
Abstract

OBJECTIVE

To identify resource use patterns and costs incurred during new episodes of bipolar disorder.

METHOD

Researchers examined Medstat MarketScan databases covering the interval of January 1, 1998, to December 31, 2002, to identify 6148 patients with new episodes of bipolar disorder as defined by the International Classification of Diseases, Ninth Revision. Resource utilization patterns and costs for the 6 months prior to the index date and for the 30 days and 1 year after the index date were examined. Differences among subcategories of bipolar patients in terms of the resources used before and after the index date were also examined.

RESULTS

The majority of the individuals in the study were female (61.3%) and the mean age was 41.9 years. Patients diagnosed as manic had higher bipolar treatment costs (p < .01) and were more likely to be hospitalized for mental health diagnoses 30 days (p < .01) and 1 year after the index diagnosis (p = .02) compared with individuals diagnosed as depressive, mixed, or other/ unknown. Median total medical costs in the 1 year after the index date were highest for those diagnosed as depressed (p = .02), while patients diagnosed as mixed bipolar had significantly more psychiatrist visits after the index date (p < .01). Approximately 15% of patients were not treated with any central nervous system medication, and over 50% of patients were treated with antidepressants.

CONCLUSION

The subcategory of bipolar disorder that an individual is diagnosed as having significantly affects resource use and costs after such diagnosis. Patients diagnosed as manic generally used more resources than other individuals. In addition, results suggest that a large proportion of individuals are not being treated in accordance with recommended treatment guidelines.

摘要

目的

确定双相情感障碍新发病例期间的资源使用模式和费用。

方法

研究人员检查了涵盖1998年1月1日至2002年12月31日期间的Medstat MarketScan数据库,以识别6148例根据《国际疾病分类》第九版定义的双相情感障碍新发病例。研究了索引日期前6个月以及索引日期后30天和1年的资源利用模式和费用。还检查了双相情感障碍患者亚类别在索引日期前后使用资源方面的差异。

结果

研究中的大多数个体为女性(61.3%),平均年龄为41.9岁。与被诊断为抑郁、混合或其他/不明类型的个体相比,被诊断为躁狂的患者双相情感障碍治疗费用更高(p <.01),并且在索引诊断后30天(p <.01)和1年(p =.02)因心理健康诊断住院的可能性更大。索引日期后1年,被诊断为抑郁的患者的医疗总费用中位数最高(p =.02),而被诊断为混合性双相情感障碍的患者在索引日期后看精神科医生的次数明显更多(p <.01)。约15%的患者未接受任何中枢神经系统药物治疗,超过50%的患者接受了抗抑郁药治疗。

结论

个体被诊断患有的双相情感障碍亚类别在诊断后对资源使用和费用有显著影响。被诊断为躁狂的患者通常比其他个体使用更多资源。此外,结果表明很大一部分个体未按照推荐的治疗指南接受治疗。

相似文献

1
Medication use, service utilization, and medical costs associated with new episodes of bipolar disorder: evidence from a retrospective claims database.与双相情感障碍新发病例相关的药物使用、服务利用及医疗费用:来自回顾性索赔数据库的证据
Prim Care Companion J Clin Psychiatry. 2007;9(4):280-6. doi: 10.4088/pcc.v09n0405.
2
The impact of treatment-resistant depression on health care utilization and costs.难治性抑郁症对医疗保健利用和成本的影响。
J Clin Psychiatry. 2002 Nov;63(11):963-71. doi: 10.4088/jcp.v63n1102.
3
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.在需要后续使用非典型抗精神病药物与非抗精神病药物进行药物治疗的多动症患儿中,兴奋剂治疗的比较治疗模式、资源利用及成本。
J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89. doi: 10.18553/jmcp.2012.18.9.676.
4
Place of care and costs associated with acute episodes and remission in bipolar I disorder.双相 I 障碍急性发作和缓解期的治疗场所和费用。
J Med Econ. 2022 Jan-Dec;25(1):1110-1117. doi: 10.1080/13696998.2022.2120264.
5
Treatment patterns, healthcare resource utilization and costs in patients with bipolar disorder, newly treated with extended release or immediate release quetiapine fumarate using US healthcare administrative claims data.使用美国医疗保健管理索赔数据评估新使用富马酸喹硫平缓释或速释制剂治疗的双相情感障碍患者的治疗模式、医疗资源利用和成本。
Clin Ther. 2013 Dec;35(12):1923-32. doi: 10.1016/j.clinthera.2013.10.005. Epub 2013 Nov 22.
6
Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder.双相情感障碍患者的抗精神病药物治疗依从性及相关心理健康护理利用情况
Clin Ther. 2008 Jul;30(7):1358-74. doi: 10.1016/s0149-2918(08)80062-8.
7
Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.与遵循美国国家质量保证委员会(NCQA)医疗效果数据和信息集(HEDIS)抗抑郁药物管理措施相关的更高成本和治疗因素:行政索赔分析
J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54. doi: 10.18553/jmcp.2006.12.1.43.
8
Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.给编辑的信:《ICD-11 与 DSM-5 心境障碍分类的趋同与分歧》
Turk Psikiyatri Derg. 2021;32(4):293-295. doi: 10.5080/u26899.
9
All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.美国新诊断多发性硬化症的全因医疗保健利用情况及相关费用。
J Manag Care Pharm. 2010 Nov-Dec;16(9):703-12. doi: 10.18553/jmcp.2010.16.9.703.
10
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.药物依从性和医疗资源利用模式的差异:老年与新型抗抑郁药在抑郁症和/或焦虑症患者中的应用
CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005.

引用本文的文献

1
Outcomes and Health Care Resource Utilization of Adult Bacterial Meningitis in the United States.美国成人细菌性脑膜炎的治疗结果及医疗资源利用情况
Neurol Clin Pract. 2021 Apr;11(2):117-126. doi: 10.1212/CPJ.0000000000000868.
2
Impact of Spinal Cord Stimulation on Opioid Dose Reduction: A Nationwide Analysis.脊髓刺激对减少阿片类药物剂量的影响:全国性分析。
Neurosurgery. 2020 Dec 15;88(1):193-201. doi: 10.1093/neuros/nyaa353.
3
Effectiveness of the Dader Method for Pharmaceutical Care on Patients with Bipolar I Disorder: Results from the EMDADER-TAB Study.Dader 法在双相 I 障碍患者药物治疗中的效果:EMDADER-TAB 研究结果。
J Manag Care Spec Pharm. 2017 Jan;23(1):74-84. doi: 10.18553/jmcp.2017.23.1.74.
4
Cost-of-illness studies for bipolar disorder: systematic review of international studies.双相情感障碍的疾病成本研究:国际研究的系统评价
Pharmacoeconomics. 2015 Apr;33(4):341-53. doi: 10.1007/s40273-014-0250-y.
5
Adverse drug interactions: moving from perception to action.药物不良相互作用:从认知到行动
Pharmacoeconomics. 2010;28(1):19-22. doi: 10.2165/11530370-000000000-00000.

本文引用的文献

1
The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.焦虑症的治疗成本:影响医疗总费用的医学及人口统计学相关因素。
Depress Anxiety. 2005;21(4):178-84. doi: 10.1002/da.20074.
2
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.全国共病调查复制研究中12个月内DSM-IV疾病的患病率、严重程度及共病情况。
Arch Gen Psychiatry. 2005 Jun;62(6):617-27. doi: 10.1001/archpsyc.62.6.617.
3
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.全国共病调查复制研究中 DSM-IV 障碍的终生患病率和发病年龄分布
Arch Gen Psychiatry. 2005 Jun;62(6):593-602. doi: 10.1001/archpsyc.62.6.593.
4
Antidepressants in bipolar disorder: the case for caution.双相情感障碍中使用抗抑郁药:需谨慎对待
Bipolar Disord. 2003 Dec;5(6):421-33. doi: 10.1046/j.1399-5618.2003.00074.x.
5
Costs of bipolar disorder.双相情感障碍的成本。
Pharmacoeconomics. 2003;21(9):601-22. doi: 10.2165/00019053-200321090-00001.
6
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania.世界生物精神病学协会联合会(WFSBP)双相情感障碍生物治疗指南,第二部分:躁狂症的治疗。
World J Biol Psychiatry. 2003 Jan;4(1):5-13. doi: 10.3109/15622970309167904.
7
Health care utilization and costs among privately insured patients with bipolar I disorder.患有双相I型障碍的私人保险患者的医疗保健利用情况及费用
Bipolar Disord. 2002 Dec;4(6):398-405. doi: 10.1034/j.1399-5618.2002.01148.x.
8
The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases.美国人群中双相谱系障碍的患病率及致残情况:考虑阈下病例对ECA数据库的重新分析
J Affect Disord. 2003 Jan;73(1-2):123-31. doi: 10.1016/s0165-0327(02)00332-4.
9
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression.世界生物精神病学协会联盟(WFSBP)双相情感障碍生物治疗指南。第一部分:双相抑郁的治疗。
World J Biol Psychiatry. 2002 Jul;3(3):115-24. doi: 10.3109/15622970209150612.
10
Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000.2000年德克萨斯双相情感障碍药物治疗共识会议小组报告。
J Clin Psychiatry. 2002 Apr;63(4):288-99. doi: 10.4088/jcp.v63n0404.